Qube Research & Technologies LTD Aziyo Biologics, Inc. Transaction History
Qube Research & Technologies LTD
- $91.4 Billion
- Q3 2025
A detailed history of Qube Research & Technologies LTD transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 20,178 shares of AZYO stock, worth $29,258. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,178
Previous 29,034
30.5%
Holding current value
$29,258
Previous $42,000
30.95%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding AZYO
# of Institutions
31Shares Held
16.6MCall Options Held
0Put Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT3.18MShares$4.62 Million0.19% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.17MShares$4.59 Million0.76% of portfolio
-
Silverarc Capital Management, LLC2.85MShares$4.13 Million0.85% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.64MShares$3.83 Million0.02% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.37MShares$1.99 Million0.04% of portfolio
About AZIYO BIOLOGICS, INC.
- Ticker AZYO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,308,720
- Market Cap $13.5M
- Description
- Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...